Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
Clinical trial NCT04738188 · UNKNOWN
Trial details
- NCT number
- NCT04738188
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-18
- Primary completion
- 2022-11-01
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.